Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 4 Study to Assess the Clinical Efficacy and Safety of Meibomian Gland Dysfunction and Dry Eye With an LED Blue Light Treatment Device

NCT03788486 is registered in ClinicalTrials.gov with Toyos Clinic as lead sponsor.

NCT NCT03788486
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03788486 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 4 Study to Assess the Clinical Efficacy and Safety of Meibomian Gland Dysfunction and Dry Eye With an LED Blue Light Treatment Device
Lead sponsor
Toyos Clinic
Phase
Not applicable
Overall status
Withdrawn
Start date
February 12, 2019
Completion date
October 7, 2020
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

meibomian gland dysfunction